[2013 update in nephrology]

Sophie de Seigneux1, Patrick Saudan2

  • 1Service de néphrologie, Département des spécialités médicales, HUG, 1211 Genève. sophie.deseigneux@hcuge.ch

Revue Medicale Suisse
|February 25, 2014
PubMed

Insights

Vasopressin antagonists benefit autosomal dominant polycystic kidney disease (ADPKD) cyst growth. Rituximab is safe and effective for ANCA vasculitis, while hemodiafiltration reduces mortality in dialyzed patients.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Critical Care

Context:

  • Autosomal dominant polycystic kidney disease (ADPKD) management.
  • Treatment strategies for ANCA vasculitis.
  • Acute kidney injury (AKI) prevention in critically ill patients.
  • Cardiovascular mortality reduction in dialyzed patients.

Purpose:

  • To evaluate the effect of vasopressin antagonists on ADPKD progression.
  • To assess the long-term safety and efficacy of Rituximab in ANCA vasculitis.
  • To determine optimal intravenous fluid strategies for AKI prevention.
  • To investigate interventions for reducing cardiovascular mortality in dialysis patients.

Summary:

  • Vasopressin antagonists demonstrated a beneficial effect on cyst growth and renal function in a large ADPKD cohort.
  • An 18-month follow-up confirmed Rituximab's safety and efficacy for induction therapy in ANCA vasculitis.
  • Evidence suggests hemodiafiltration with high ultrafiltration volume significantly decreases mortality in dialyzed patients, though calcimimetics' role remains inconclusive.

Impact:

  • Provides novel therapeutic insights for ADPKD.
  • Reinforces Rituximab as a viable treatment for ANCA vasculitis.
  • Offers guidance on fluid management to mitigate AKI.
  • Highlights effective strategies for improving survival in dialysis patients.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
788
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
527
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549